Phase IIb randomised clinical trial repurposing ATRA as a stromal targeting agent in a novel drug combination for pancreatic cancer (STARPAC 2)

Project: Research

Project Details

StatusFinished
Effective start/end date1/08/20191/08/2022

Collaborative partners

  • King's College London
  • BARTS HEALTH NHS TRUST
  • Christie NHS Foundation Trust
  • Greater Glasgow Health Board
  • University of Glasgow
  • Queen Mary University of London (lead)
  • University of Manchester

Funding

  • MRC Medical Research Council: £3,365.60